Evidence Explorer / MS-N018

Evidence at a glance

• Population: Adults receiving radiotherapy for colorectal or head-and-neck cancer in two small randomized trials.
• Intervention: Repeated, individualized counseling using ordinary foods, compared with protein supplements or usual unrestricted intake.
• Benefit: Better energy intake, nutritional status and quality-of-life measures; the counseling arm generally outperformed supplement-only care.
• Boundary: Supportive nutrition evidence—not proof of improved tumor control or survival.

What the human evidence found

A colorectal-cancer trial randomized 111 outpatients, 37 per group, to individualized food-based counseling, usual diet plus protein supplements, or usual intake. At radiotherapy completion, energy intake increased in both active groups but more with counseling; intake fell with usual care. Nutritional-status and quality-of-life advantages were reported through three months.

A separate head-and-neck trial randomized 75 patients, 25 per group, using the same three-arm design. Food-based counseling improved intake and patient-centered outcomes during and after radiotherapy. These are older, single-program studies; they show the value of structured dietitian contact more clearly than they establish one universal menu.

The long-term colorectal follow-up concerns the same original trial—not an independent trial—and should not be double-counted.

Limits and what this cannot establish

The trials were small, conducted by one research group, and used older radiotherapy-era supportive care. Blinding was not practical. Several outcomes were self-reported, and exact clinically meaningful thresholds were not consistently reported in accessible abstracts.

This record does not establish that oral supplements are ineffective. A supplement may be useful when eating is not enough; the key finding is that handing over a product is not equivalent to individualized assessment and follow-up.

Safety and practical context

Rapid weight loss, dehydration, swallowing difficulty, uncontrolled diarrhea or inability to meet needs requires prompt oncology and dietitian assessment. Advice must fit the radiation field, diabetes or kidney disease, ostomy function, texture needs and current symptoms.

Funding and conflict details were not fully re-extracted for every report in this appraisal.

Questions for the care team

• Can I see an oncology dietitian early rather than waiting for substantial weight loss?
• What intake or weight threshold should trigger oral supplements, tube feeding or other support?
• How should the plan change if swallowing, diarrhea, nausea or taste worsens?

Sources checked

• Colorectal radiotherapy randomized trial (PMID 15684319)
• Head-and-neck radiotherapy randomized trial (PMID 15920748)
• Long-term follow-up of the colorectal trial (PMID 23134880; same trial)
• ESPEN practical guideline: clinical nutrition in cancer (PMID 33946039)

Appraisal date: October 14, 2026. Last literature search: October 14, 2026.

Educational evidence summary, not medical advice. Research regimens describe what was studied; they are not personal prescribing instructions and should not replace cancer treatment or individualized supportive care.